Search company, investor...

Predict your next investment

MTIP company logo
Venture Capital
mtip.ch

Investments

16

Portfolio Exits

1

Funds

2

Partners & Customers

1

About MTIP

MTIP is a Swiss-based growth investor that specializes in scaling up health tech companies in rapidly expanding global markets. The firm invests in digitally-connected, decentralized, and patient-centric medical technology leaders, based primarily in Europe, with offerings that provide clear health-related economic benefits. Its entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors. The firm was founded in 2014 and is based in Basel, Switzerland.

Headquarters Location

Rittergasse 35

Basel, 4051,

Switzerland

+41 61 551 02 50

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest MTIP News

MTIP Investments

16 Investments

MTIP has made 16 investments. Their latest investment was in Apricity as part of their Series B on September 9, 2022.

CBI Logo

MTIP Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/5/2022

Series B

Apricity

$16.86M

Yes

9

6/23/2022

Series A

LynxCare

$21.05M

Yes

1

10/4/2021

Series B

Mediktor

$12.79M

Yes

2

9/1/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

8/10/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/5/2022

6/23/2022

10/4/2021

9/1/2021

8/10/2021

Round

Series B

Series A

Series B

Series C

Series A

Company

Apricity

LynxCare

Mediktor

Subscribe to see more

Subscribe to see more

Amount

$16.86M

$21.05M

$12.79M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

9

1

2

10

10

MTIP Portfolio Exits

1 Portfolio Exit

MTIP has 1 portfolio exit. Their latest portfolio exit was Blueprint Genetics on January 22, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/22/2020

Acquired

$99M

1

Date

1/22/2020

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

1

MTIP Fund History

2 Fund Histories

MTIP has 2 funds, including MTIP Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/7/2021

MTIP Fund II

$250M

2

4/4/2017

MedTech Innovation Partners Fund I

$99M

10

Closing Date

12/7/2021

4/4/2017

Fund

MTIP Fund II

MedTech Innovation Partners Fund I

Fund Type

Status

Amount

$250M

$99M

Sources

2

10

MTIP Partners & Customers

1 Partners and customers

MTIP has 1 strategic partners and customers. MTIP recently partnered with Mediktor on September 9, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

9/24/2021

Partner

Spain

Date

9/24/2021

Type

Partner

Business Partner

Country

Spain

News Snippet

Sources

MTIP Team

4 Team Members

MTIP has 4 team members, including current Founder, Founding Partner, Hans-Florian Zeilhofer.

Name

Work History

Title

Status

Hans-Florian Zeilhofer

Founder, Founding Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Hans-Florian Zeilhofer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Founding Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.